---
title: "Amaros AI: AI platform turning ophthalmology clinical data into insights for trials, RWE and commercial teams"
url: https://emrr.uz/amaros
language: en
updated: 2026-11-18T13:47:10Z
source: emrr (https://emrr.uz)
---

# Amaros AI

AI platform turning ophthalmology clinical data into insights for trials, RWE and commercial teams

[amaros.ai](https://amaros.ai/)

- **Industry**: HealthTech, AI / ML
- **Founded**: 2019
- **Based in**: United States

## Verified revenue: not connected yet

Is Amaros AI yours? Claim this page and connect Stripe, the App Store or Google Play: your MRR and growth show here, read straight from the source.

[Claim it if it’s yours](https://panel.emrr.uz/reserve/amaros)

## About

Amaros AI builds AmarosEngine, an AI platform for ophthalmology. It combines EMRs, imaging, genetics, provider notes and payer claims into structured insights for clinical trials, real-world evidence and commercial teams. It was founded in 2019 in Silicon Valley, US, and is backed by Armenia-based SmartGate VC.

## Team

- **Vartan Ghazarossian**, Co-founder and CEO (Founder)
- **Ben Toker**, Co-founder and President (Founder)

## Audience

Followers on social networks

- [X @amarosai_](https://x.com/amarosai_)
- [LinkedIn amaros-ai](https://www.linkedin.com/company/amaros-ai/)

Profile data from Stanbase.

Updated 18 November 2026

[This page in Markdown](https://emrr.uz/amaros.md)

[Get your verified page](https://emrr.uz/): Connect Stripe, the App Store or Google Play in two minutes and get a page like this one. emrr reads every figure itself, so investors don’t have to take your word for it. Free while MRR is under $1,000.
